Skip to main content
TipRanks
Go Ultimate75% OFF

Atea Pharmaceuticals (AVIR) Drug Pipeline

248 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Buprenorphine/Naloxone + Bem/Rzr, Methadone +Bem/RzrHealthy Volunteer StudyPhase IRecruitingDrug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or MethadoneDec 18, 2025―
Bemnifosbuvir-Ruzasvir, Sofosbuvir-VelpatasvirHepatitis C Virus Chronic Infection, Hepatitis C, Chronic, Hepatitis C, Hepatitis C Virus InfectionPhase IIIActive Not RecruitingC-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCVJun 10, 2025
Treatment A-Bemnifosbuvir/Ruzasvir Fdc Administered Fasting, Treatment B-Omeprazole 20 Mg Dose Administered Fasting, Treatment C-Bemnifosbuvir/Ruzasvir Fdc Administered Simultaneously With 20 Mg Dose Of Omeprazole Fasting, Treatment D-Bemnifosbuvir/Ruzasvir Fdc Administered 0.5 Hour Prior To 20 Mg Dose Of Omeprazole, Treatment E-Omeprazole 40 Mg Administered Fasting, Treatment F-Bemnifosbuvir/Ruzasvir Fdc Administered 2 Hours After 40 Mg Dose OmeprazoleHealthy Volunteer StudyPhase ICompletedDrug-drug Interaction Study of Omeprazole and Bemnifosbuvir/RuzasvirMay 19, 2025―
Digoxin Vs Digoxin + Bem/Rzr Vs Digoxin + 2H Bem/Rzr, Rosuvastatin Vs Rosuvastatin + Bem/Rzr Vs Rosuvastatin + 2H Bem/RzrHealthy Volunteer StudyPhase ICompletedDrug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and RosuvastatinMar 27, 2025―
Bemnifosbuvir/Ruzasvir As A Fixed-Dose CombinationHealthy Volunteer Study, Renal Impairment, Hepatic ImpairmentPhase IRecruitingStudy of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic FunctionMar 24, 2025
Bemnifosbuvir-Ruzasvir, Sofosbuvir-VelpatasvirHepatitis C Virus Chronic InfectionPhase IIIActive Not RecruitingC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCVMar 07, 2025
Bemnifosbuvir, RuzasvirHepatic Cirrhosis, Hepatitis C, Chronic, Hepatitis C, Chronic Hepatitis C Virus, HcvPhase IICompletedA Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVJun 06, 2023―
BemnifosbuvirCovid-19, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars Cov 2 Infection)Phase IIICompletedSUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19Nov 26, 2022―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Atea Pharmaceuticals, Inc. (AVIR) have in its pipeline
Atea Pharmaceuticals AVIR is currently developing the following drugs: Buprenorphine/Naloxone + Bem/Rzr, Methadone +Bem/Rzr, Bemnifosbuvir-Ruzasvir, Sofosbuvir-Velpatasvir, Treatment A-Bemnifosbuvir/Ruzasvir Fdc Administered Fasting, Treatment B-Omeprazole 20 Mg Dose Administered Fasting, Treatment C-Bemnifosbuvir/Ruzasvir Fdc Administered Simultaneously With 20 Mg Dose Of Omeprazole Fasting, Treatment D-Bemnifosbuvir/Ruzasvir Fdc Administered 0.5 Hour Prior To 20 Mg Dose Of Omeprazole, Treatment E-Omeprazole 40 Mg Administered Fasting, Treatment F-Bemnifosbuvir/Ruzasvir Fdc Administered 2 Hours After 40 Mg Dose Omeprazole, Digoxin Vs Digoxin + Bem/Rzr Vs Digoxin + 2H Bem/Rzr, Rosuvastatin Vs Rosuvastatin + Bem/Rzr Vs Rosuvastatin + 2H Bem/Rzr, Bemnifosbuvir/Ruzasvir As A Fixed-Dose Combination, Bemnifosbuvir, Ruzasvir, Bemnifosbuvir. These drug candidates are in various stages of clinical development as the company works toward FDA approval.